Countries in the Americas will have access to HPV9 vaccine through PAHO's Revolving Fund starting in mid-2025
February 6, 2025
Washington, DC, February 5, 2025 – The Pan American Health Organization (PAHO) announced that the non-valent HPV vaccine will be available in countries of the Americas through its Revolving Fund for Vaccine Access beginning in July 2025. This will facilitate more affordable and effective access to the vaccine, which provides protection against 9 strains of the human papillomavirus (HPV), associated with various types of cancer.
This initiative should provide vaccination programs with more tools to protect their populations against the most prevalent genotypes in cervical cancer and reduce the burden of HPV-related diseases: the non-valent vaccine has 5 more valences than its previous version (quadrivalent vaccine) against these genotypes.
All vaccines included in the PAHO Revolving Fund portfolio are prequalified by the World Health Organization (WHO) or a reference authority, seeking to offer quality and safe health technologies, aligned with technical criteria.
“The inclusion of the 9-valent HPV vaccine is a step forward in the fight against HPV-related cancers and an important tool for countries’ immunization programs,” said Santiago Cornejo, Executive Director of the PAHO Revolving Fund. “By working together, we can make lifesaving vaccines more accessible to all and continue to advance toward the goal of eliminating cervical cancer by 2030.”
The 9-valent HPV vaccine is recommended for people aged 9 to 26 years, depending on each country's vaccination schedule.
Vaccination is a key element of PAHO Elimination Initiative, which aims to end more than 30 diseases by 2030, including cervical cancer. The goal is to vaccinate 90 % girls within 15 years with at least one dose of HPV vaccine.
The PAHO Revolving Fund allows countries to combine their purchasing power to negotiate better prices and ensure a continuous and timely supply of vaccines and related supplies. This approach reduces costs and simplifies the acquisition process for participating countries.
English 
French